-
The prospects for the development of Chinese medicine overseas markets are considerable, and these bottlenecks still need to be broken
Time of Update: 2021-12-03
Therefore, if pharmaceutical companies want to better guarantee drug safety, they must use technological innovation to develop modern Chinese medicine scientific research and industrial production technology to continuously promote the development of the Chinese medicine industry in a high-quality direction .
-
Academician Chen Liquan and others write articles on the development strategy of my country's new energy materials
Time of Update: 2021-11-19
The article proposes to improve the top-level planning, increase support for innovation-driven policies, cultivate superior enterprises, carry out the construction of production and application demonstration platforms, and strengthen the construction of talent teams in order to achieve the leapfrog development of new energy materials in China .
-
The supervision of Chinese medicine is continuously upgraded
Time of Update: 2021-11-03
In this context, in order to regulate the development and use of traditional Chinese medicines, the state has also begun to issue a series of documents to revise and improve the product manuals of traditional Chinese medicines .
-
Under the general trend of pharmaceutical reform, the personnel changes of pharmaceutical company executives will become more and more frequent
Time of Update: 2021-10-21
Recently, the transfer of senior management in the pharmaceutical industry has been relatively frequent, and the directors, deputy general managers, and supervisors of many listed companies have begun to change one after another, including Hengrui, Northeast Pharmaceutical, and Kangchen Pharmaceutical .
-
Unexpected: To deal with difficult eczema, sex hormone synthesis genes are the key
Time of Update: 2021-10-01
They found that when they reduce the activity of this gene, the level of sex hormones will drop and the secretion of skin sebum will increase .
-
How does "machine learning" help new drug development
Time of Update: 2021-10-01
Machine learning (ML), as a branch of artificial intelligence, has multiple methods used in the drug discovery process to predict the molecular characteristics, biological activities, interactions, and adverse reactions of new chemical entities .
-
Do these 8 steps, and the diagnosis and treatment of dizziness/vertigo diseases can be easily achieved
Time of Update: 2021-09-10
Clinically, if these non-specific dizziness patients are included in the dizziness and vertigo disease spectrum, it is easy to cause generalization .
-
The world's third BTK-PROTAC starts clinical trial
Time of Update: 2021-08-28
Article source: Medical Rubik's Cube InfoAuthor: Shi BeiOn August 16, BeiGene registered the US Phase I study of BTK protein degradation agent (BTK-PROTAC) BGB-16673 on the American Clinical Network to treat B-cell malignancies.
-
J Neurol Neurosurg Psychiatry: Cerebrovascular disease is a contributing factor for cerebral hemorrhage in patients on anticoagulation therapy
Time of Update: 2021-08-02
Cerebral small vessel disease (SVD) is the most common cause of non-traumatic spontaneous intracerebral hemorrhage (ICH).
A meta-analysis of randomized controlled trials showed that oral anticoagulants vitamin K antagonists and direct oral anticoagulants (apixaban, dabigatran, edoxaban, and rivaroxaban) are risk factors for cerebral hemorrhage .
-
The State Drug Administration issued a notice on the issuance of the "Administrative Measures for Drug Inspection (Trial
Time of Update: 2021-07-31
On May 28, in order to implement the "Drug Administration Law" and the "Vaccine Administration Law", further standardize drug inspection behavior, and promote drug supervision work to adapt to the n
-
Multiple clinical research data of dual antibodies KN046 and KN026 will be unveiled in ASCO 2021, covering multiple tumor types such as lung cancer and pancreatic cancer
Time of Update: 2021-06-17
*Only for medical professionals to read and reference. Recently, 3 clinical research data of KN046 (PD-L1/CTLA-4 bispecific antibody) will be presented in the ASCO 2021 annual meeting in the form of
-
The first CAR-T therapy targeting BCMA was approved by the FDA for marketing
Time of Update: 2021-04-19
The study recruited 127 patients with relapsed/refractory multiple myeloma who had previously received at least third-line treatment including immunomodulators, proteasome inhibitors, and anti-CD38 antibodies.
-
Renfu Medicine: Mifepristone tablets passed the consistency evaluation of generic drugs
Time of Update: 2021-03-29
, a subsidiary of the company, received the "Drug Supplementary Application Approval Notice" from the State Food and Drug Administration on mifepristone tablets (notice Book number: 2020B05143), the drug passed the generic drug quality and efficacy consistency evaluation.
-
The potential COVID-19 drug azithromycin may increase the risk of heart disease
Time of Update: 2021-03-02
"Our findings should lead researchers and clinicians to view azithromycin as a potential treatment for COVID-19 stoppages, and we found that taking these drugs together with drugs that affect electrical impulses in the heart can increase heart events by 40 percent, including fainting, cardiac arrest, and even cardiac arrest," said Haridarshan Patel, a researcher in the Department of Pharmacology, Results and Policy at the UIC School of Pharmacy.
-
Anhui to promote the construction of medical complex, large hospital expert number can be hung in the community
Time of Update: 2021-02-07
Recently, our province issued the "guidance on promoting the construction of medical complexes ( draft for comments)" (hereinafter referred to as "opinion draft"), according to the "opinion draft", by 2020, the formation of a more perfect policy system of medical associations, the proportion of residents at the grass-roots level of the first consultation reached 70%, the county-level consultation rate increased to 90%.
